Coordinated Care Enhances Access to Hepatitis C Antiviral Treatment
Coordinated treatment programs may improve treatment outcomes in patients with hepatitis C infection.
All articles by Infectious Disease Advisor Contributing Writer
Targeted Counseling Needed for Women in HIV Prevention Trials
Despite counseling and care that was provided to participants, the risk for pregnancy, sexually transmitted infections, and HIV infection remained high.
Successful Screening and Referral for HIV, Hepatitis C in a Trauma Population
Investigators added hepatitis c virus and HIV screening tests to standard trauma activation laboratory orders.
Predictors of Influenza Vaccine Acceptance in Inflammatory Rheumatic Diseases
A direct recommendation from physicians had the greatest effect on patients’ positive vaccination status.
Predictors of Survival in HIV/HCV Co-Infected Patients With HCC
The strongest survival prognostic factor in HCC with co-infection of HIV and HCV is radiological aggressiveness of the tumor.
Pretreatment Drug Resistance Testing Optimizes Antiretroviral Therapy in INSTI Regimens
The effect of transmitted drug resistance on response to first-line regimens in naive patients taking a three-drug antiretroviral therapy was examined.
Text Messaging Self-Reports: A Useful Approach for Assessing PrEP Adherence in MSM
Patients with higher self-reported adherence following text messaging reminders had higher PrEP drug concentrations.
Single High-Dose Liposomal Amphotericin B Effectively Treats HIV-Associated Cryptococcal Meningitis
Single high-dose liposomal amphotericin B treatment was non-inferior to standard dose 14-day amphotericin B treatment in HIV-associated cryptococcal meningitis.
Latent Toxoplasma Infection Occurs More Frequently in Schizophrenia
Investigators examined whether latent toxoplasma infection was associated with higher levels of psychotic symptomatology.
Sofosbuvir, Daclatasvir Combination Effective for Hepatitis C-Related Cirrhosis
Direct-acting antiviral therapy has dramatically improved response rates for individuals with hepatitis C virus genotype 4.
Next post in Hepatitis Advisor
